Safety, Efficacy, and Pharmacokinetics of Tafamidis in Patients With Transthyretin-mediated Amyloidosis Post Orthotopic Heart Transplantation
Clinical trial NCT05489523 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05489523
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-01
- Primary completion
- 2027-05-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.